Like its competitors, Google continues to experiment with low- and no-code tools that harness agentic AI for business ...

The startup is developing a kind of macrocyles, which share strengths of both small molecules and biologics, to make oral ...

Obsidian Therapeutics, Inc., a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced that Chief Executive Officer, Madan Jagasia, M.D., will present at ...

Researchers have identified six new biomarkers that could detect kidney injury faster and with more sensitivity, advancing safer drug development and improving health outcomes for patients. The new ...

By the end of March, the regulator could clear a highly anticipated pain drug from Vertex and a heart drug that’s critical to Alnylam’s future.

Drug-induced kidney injury, or nephrotoxicity, is a common complication in clinical medicine that happens when drugs damage ...

Russia and other hostile states have become increasingly brazen in adopting “gray zone” attacks against Europe and the United States, leaving defense officials with a dilemma: How to respond ...

Al Jazeera’s Moath al-Kahlout, one of the few journalists in northern Gaza, has been to the scene of an Israeli attack. Hamas tells news agencies it has approved a list of 34 captives to be ...

Google has unveiled a detailed whitepaper on the development and functionality of Generative AI agents. Google unveils ...

Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today published a letter to shareholders highlighting the company ...

Z2 Investment Management ("Z2") a lower middle market private investment fund, is pleased to announce an investment in Coastline Wealth Management ("Coastline"), an independent wealth management ...

Google has published a comprehensive whitepaper that explores the development and functionality of Generative AI agents. This ...